ID   LD600
AC   CVCL_EJ14
DR   cancercelllines; CVCL_EJ14
DR   Cosmic; 943740
DR   Wikidata; Q54902369
RX   PubMed=9850064;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Gln (c.239G>A) (p.Pro94Pro, c.282G>A); ClinVar=VCV000376385; Zygosity=Unspecified (PubMed=9850064).
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
RX   PubMed=9850064;
RA   Markl I.D.C., Jones P.A.;
RT   "Presence and location of TP53 mutation determines pattern of
RT   CDKN2A/ARF pathway inactivation in bladder cancer.";
RL   Cancer Res. 58:5348-5353(1998).
//